Viewing Study NCT05682859


Ignite Creation Date: 2025-12-24 @ 2:42 PM
Ignite Modification Date: 2025-12-27 @ 7:56 PM
Study NCT ID: NCT05682859
Status: RECRUITING
Last Update Posted: 2023-11-18
First Post: 2022-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)
Sponsor: Jacob Pontoppidan Thyssen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module